Diagnosis, management and screening of early localised prostate cancer
Selley S, Donovan J, Faulkner A, Coast J, Gillat D
Record ID 31998008187
To summarise the available evidence on the diagnosis, management and screening of early localised prostate cancer.
Authors' recommendations: There is no justification for the introduction of population screening. PSA testing should be limited to men with clinical evidence of prostate cancer who have a life expectancy of more than 10 years. Serum PSA measurement is recommended for monitoring disease progression. The paucity of research evidence suggests that radical treatments should not be performed without the accompanying collection of pre-operative and follow-up data a coordinated programme of audit. Conservative management is a reasonable treatment option for men with localised disease, and patients should be informed about the evidence currently available and encouraged to participate fully in decisions about their management. There is no justification for the routine use of PSA testing in primary care.
Authors' methods: Review
Project Status: Completed
URL for project: http://www.hta.ac.uk/901
Year Published: 1997
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
- Mass Screening
- Prostatic Neoplasms
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: email@example.com
Contact Email: firstname.lastname@example.org
Copyright: 2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.